Bristol-Myers Squibb Target, Estimates Under Review At Goldman Sachs By: Benzinga via Benzinga April 28, 2016 at 13:05 PM EDT Bristol-Myers Squibb Co (NYSE: BMY) reported strong 1Q results, while raising its guidance for 2016. 1Q Beat Goldman Sachs’ Jami ... Read More >> Related Stocks: Bristol-Myers Squibb